生物科技企業與專業製藥企業的行銷及販賣最佳實踐方案

本報告已在2011年12月21日停止出版。

簡介

目錄

Abstract

In this report, we present the results of a study we performed in Europe in 2005 to identify best practices in marketing and sales strategies among high-performing and profitably growing biotech and midsize specialized pharmaceutical companies. The survey stressed the importance of a company's commercialization model, its organizational structure, and its allocation of marketing and sales functions during different stages of business development and at different corporate levels (i.e., globally, regionally across Europe, and at the local country level). We surveyed 18 high-performing companies with annual revenues of more than $100 million and gained valuable insight into the optimal methods of pharmaceutical and biotech commercial organization in Europe.

Table of Contents

• High-Performing Biotech and Specialized Pharmaceutical Companies
• Marketing and Sales Organization Survey
• Operational Models for Marketing and Sales
• Criteria for Choosing a Partner
• Establishing Country Affiliates
• Organizational Structure
• Retained European Headquarters Model
• Reduced European Headquarters Model
• Best Practices in Allocating Roles and Responsibilities when Expanding into EU-5 Markets
• Portfolio and Marketing Strategies Need Global Control
• Clinical Trials, Health Economics, and KOL Management
• Synergistic Benefits from Regulatory Affairs and Marketing and Sales Support
• Country-Specific Requirements at the Local Level
• Common Mistakes when Expanding into EU-5 Markets
• Path for Evaluating an Optimal Organization

• Figure 1 Biotech and Specialized Pharma Companies Taking Part in the Survey
• Figure 2 Organization Choices for Marketing and Sales
• Figure 3 Predominant Operational Marketing and Sales Models Used by Biotech and Midsize Specialized Pharma Companies in Europe
• Figure 4 Drivers Behind the Choice of Operational Models for Marketing and Sales in the European Union
• Figure 5 Two Models of European Union Headquarters Development Over Time
• Figure 6 Perceived Best Practices for Allocation of Marketing and Sales Functions
• Figure 7 Bottom-Up Evaluation Process for an Optimal Organizational Development Plan
• Table 1 Preferences in Choosing the Size of an External Sales and Marketing Partner
• Table 2 Profile of the "Ideal" European General Manager
• Table 3 Most Common Mistakes when Expanding into the European Union-5

相關商品

製藥企業相關市場調查報告書

生物標記相關合作契約
Biomarker Partnering Terms and Agreements
價格 : US $ 2695
出版日期 : 2012年02月

最佳實務：轉譯研究-朝向產業轉換前進
Best Practices: Translational Research - Positive Steps on the Path to Industry Transformation
價格 : US $ 4500
出版日期 : 2011年12月

製藥產業的合作，授權，投資，收購與合併交易趨勢:2011年12月
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011
價格 : US $ 1000
出版日期 : 2011年12月

Decision Resources, Inc.發行的製藥相關市場調查報告書

傳染病疫苗開發平台:競爭檢討

Special Report: The Infectious Disease Vaccine Pipeline--A Competitive Review

價格 : US $ 9200

出版日期 : 2011年06月

感染疾病疫苗:未滿足需求和對醫藥品產業來說的機會

Special Report: Infectious Disease Vaccines--Unmet Needs and Opportunities for Pharma

價格 : US $ 9200

出版日期 : 2011年06月

自閉症譜系障礙:高未滿足需求創造出很大的市場機會

Special Report: Autism Spectrum Disorders--High Unmet Needs Create Significant Market Opportunities

價格 : US $ 9200

出版日期 : 2011年06月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!